Selected article for: "acute sars cov respiratory syndrome coronavirus and lymph node"

Author: Xiao, Y.; Meng, Q.; Yin, X.; Guan, Y.; Liu, Y.; Li, C.; Wang, M.; Liu, G.; Tong, T.; Wang, L.-F.; Kong, X.; Wu, D.
Title: Pathological Changes in Masked Palm Civets Experimentally Infected by Severe Acute Respiratory Syndrome (SARS) Coronavirus
  • Cord-id: 8cfyen86
  • Document date: 2008_3_17
  • ID: 8cfyen86
    Snippet: Masked palm civets are highly susceptible to infection with the severe acute respiratory syndrome coronavirus (SARS-CoV). Infected animals become less aggressive and develop pyrexia, lethargy and diarrhoea. The present study describes the spectrum of histopathological changes in the lung, spleen, lymph node, liver, small intestine, kidney and cerebrum of civets infected experimentally with SARS-CoV. In-situ hybridization (ISH) with probes specific for the RNA polymerase gene demonstrated viral R
    Document: Masked palm civets are highly susceptible to infection with the severe acute respiratory syndrome coronavirus (SARS-CoV). Infected animals become less aggressive and develop pyrexia, lethargy and diarrhoea. The present study describes the spectrum of histopathological changes in the lung, spleen, lymph node, liver, small intestine, kidney and cerebrum of civets infected experimentally with SARS-CoV. In-situ hybridization (ISH) with probes specific for the RNA polymerase gene demonstrated viral RNA in the lung, small intestine and cerebrum only. In-situ labelling was employed in order to demonstrate cellular apoptosis in the cerebrum, but there was no evidence of apoptosis within the myocardium. These results indicate that SARS-CoV causes multi-organ pathology in civets, similar to that observed in human SARS patients. These parallels suggest that civets may be used as an animal model of this infection to gain insight into the pathogenesis of SARS and for evaluation of candidate vaccines and antiviral drugs.

    Search related documents:
    Co phrase search for related documents
    • live animal and lymph nodes: 1
    • loss lethargy and lymph node: 1, 2, 3
    • loss lethargy and lymph nodes: 1, 2, 3, 4
    • lung pathology and lymph node: 1
    • lung pathology and lymph nodes: 1, 2